Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Seifert

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Clinical Breast Cancer|May 22, 2002
Young age as an independent adverse prognostic factor in premenopausal patients with breast cancerPeter C Dubsky, Michael F X Gnant, Susanne Taucher, et al.
Annals of Surgical Oncology|December 31, 2011
Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)Christoph Tausch, Susanne Taucher, Peter Dubsky, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2014
CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorderYifu Fang, Charles Ginsberg, Michael Seifert, et al.
Biology Direct|May 14, 2024
Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesiclesKonrad Grützmann, Karsten Salomo, Alexander Krüger, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2026
GOT1 Inhibition Induces Extracellular Matrix Remodeling in Pancreatic CancerRodrigo Curvello, Sandra Hauser, Michael Seifert, et al.
Cancers|April 23, 2020
Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted SequencingPatricia Johansson, Ludger Klein-Hitpass, Bettina Budeus, et al.
Molecular Cancer|February 20, 2024
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcomeFelix Broghammer, Irina Korovina, Mahesh Gouda, et al.
Lancet (London, England)|August 9, 2005
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trialRaimund Jakesz, Walter Jonat, Michael Gnant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5Raimund Jakesz, Hubert Hausmaninger, Ernst Kubista, et al.
Neuro-Oncology|February 16, 2017
Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomasKhalil Abou-El-Ardat, Michael Seifert, Kerstin Becker, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Clinical Breast Cancer|May 22, 2002
Young age as an independent adverse prognostic factor in premenopausal patients with breast cancerPeter C Dubsky, Michael F X Gnant, Susanne Taucher, et al.
Annals of Surgical Oncology|December 31, 2011
Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)Christoph Tausch, Susanne Taucher, Peter Dubsky, et al.
Journal of the American Society of Nephrology : JASN|March 1, 2014
CKD-induced wingless/integration1 inhibitors and phosphorus cause the CKD-mineral and bone disorderYifu Fang, Charles Ginsberg, Michael Seifert, et al.
Biology Direct|May 14, 2024
Identification of novel snoRNA-based biomarkers for clear cell renal cell carcinoma from urine-derived extracellular vesiclesKonrad Grützmann, Karsten Salomo, Alexander Krüger, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 13, 2026
GOT1 Inhibition Induces Extracellular Matrix Remodeling in Pancreatic CancerRodrigo Curvello, Sandra Hauser, Michael Seifert, et al.
Cancers|April 23, 2020
Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted SequencingPatricia Johansson, Ludger Klein-Hitpass, Bettina Budeus, et al.
Molecular Cancer|February 20, 2024
Resistance of HNSCC cell models to pan-FGFR inhibition depends on the EMT phenotype associating with clinical outcomeFelix Broghammer, Irina Korovina, Mahesh Gouda, et al.
Lancet (London, England)|August 9, 2005
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trialRaimund Jakesz, Walter Jonat, Michael Gnant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2002
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5Raimund Jakesz, Hubert Hausmaninger, Ernst Kubista, et al.
Neuro-Oncology|February 16, 2017
Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomasKhalil Abou-El-Ardat, Michael Seifert, Kerstin Becker, et al.
Pageof 10